GBT

Global Blood Therapeutics, Inc.
GBT

Overview Fund Activity
Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

136 hedge funds and large institutions have $1.22B invested in Global Blood Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 40 reducing their positions, and 19 closing their positions.

Holders
136
Holders Change
+2
Holders Change %
+1.49%
% of All Funds
3.4%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
24
Increased
50
Reduced
40
Closed
19
Calls
$14.9M
Puts
$4.44M
Net Calls
+$10.4M
Net Calls Change
+$5.69M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$62.8M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$44M
3
PA
3
Perceptive Advisors
New York
$132M
4
GPP
4
Great Point Partners
Connecticut
$17.4M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$99.7M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$8.28M
2
RG
2
Redmile Group
California
$0
3
Lord, Abbett & Co
3
Lord, Abbett & Co
New Jersey
$4.21M
4
PC
4
PointState Capital
New York
$0
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$162M
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
151
Simplex Trading
Illinois
– -$88K -3,239 Closed
NIT
152
NumerixS Investment Technologies
British Columbia, Canada
– -$79K -2,900 Closed
FO
153
FT Options
Illinois
– -$49K -1,805 Closed
PAM
154
Panagora Asset Management
Massachusetts
– -$20K -714 Closed
SO
155
STRS Ohio
Ohio
– -$13K -500 Closed
3 4 5 6
7